Greenland Mines Ltd Warrant (GRMLW)

• 1 day: 3.65%
• 5 days: -30%
• 1 month: -19.23%
• 3 months: 109.58%
• 6 months: 61.29%
• Year to date: 98.3%
• 1 year: -42.43%
• 5 years: 50%
• 10 years: 50%
• Sector: Healthcare
• Industry: Biotechnology

About: Greenland Mines Ltd develops essential medicines for the treatment of chronic diseases - cancer, cardiovascular, and neurodegenerative disorders. The Company operates as a single reporting segment focused on developing essential medicines for these chronic diseases. The Company has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and proprietary patented technologies involving melanocortin receptor-binding molecules and a gene therapy platform that introduces a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases.

Employees: 5